Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
32 participants
INTERVENTIONAL
2010-02-28
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Sex Steroids on the Serotonin System
NCT02715232
Effects of Sex Steroid Hormones on Human Brain Function, Structure and Connectivity
NCT01292785
Cross-sex Hormone Therapy and Neuronal Plasticity
NCT03651427
Sexuality in Transmen During Hormone and Operative Treatment
NCT03637920
Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin
NCT04330677
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hormone treatment for MtF
* cyproterone acetate
* estradiol
* alpha-5-reductase-inhibitor
Cyproterone Acetate
50mg per day
Estradiol
100 microgram TTS twice a week
5-alpha reductase inhibitor
1mg daily
hormone treatment for FtM
* testosterone undecanoate
* lynestrenol
Testolactone undecanoate
4ml i.m.
Lynestrenol
2/day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Testolactone undecanoate
4ml i.m.
Lynestrenol
2/day
Cyproterone Acetate
50mg per day
Estradiol
100 microgram TTS twice a week
5-alpha reductase inhibitor
1mg daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no previous sex hormone medication
* willingness to sign the written informed consent
Exclusion Criteria
* steroid hormone treatment within 6 months prior inclusion
* treatment with psychotropic agents such as selective serotonin reuptake inhibitors (SSRIs)
* any implant or stainless steel graft
* positive urine pregnancy test in women at the screening visit at each PET day
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rupert Lanzenberger
A/Prof. PD Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rupert Lanzenberger, MD A/Prof
Role: PRINCIPAL_INVESTIGATOR
Medical University of Vienna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Psychiatry and Psychotherapy, Medical University of Vienna
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kranz GS, Wadsak W, Kaufmann U, Savli M, Baldinger P, Gryglewski G, Haeusler D, Spies M, Mitterhauser M, Kasper S, Lanzenberger R. High-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People. Biol Psychiatry. 2015 Oct 15;78(8):525-33. doi: 10.1016/j.biopsych.2014.09.010. Epub 2014 Sep 23.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AP13214ONB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.